EdJeraldHendricksMDFASBP

PubMed

• 40 citations
  Addiction potential of phentermine prescribed during long-term treatment of obesity.
  Ed J. Hendricks, Manit Srisurapanont, Stacy L. Schmidt, M Haggard, S Souter
  International Journal of Obesity. 2014-02-01
• 69 citations
  Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity.
  Ed J. Hendricks, Frank L. Greenway, Eric C. Westman, Alok Gupta
  Obesity. 2011-12-01
• 5 citations
  How Physician Obesity Medicine Specialists Treated Obesity before 2012 New Drug Approvals
  Stacy L. Schmidt, David A. Bryman, Frank L. Greenway, Ed J. Hendricks
  Obesity Surgery. 2015-01-01

Journal Articles

• Phentermine pharmacotherapy for Weight Management in Overweight to Morbidly Obese Subjects does not alter seated resting office blood pressure 475P.  
  Hendricks EJ, Greenway F, Westman E, Gupta AK, Obesity 18, S2(Supplement 2):S151
• Symptoms Observed after Abrupt Phentermine Cessation 223-P.  
  Hendricks EJ, Greenway FL, Obesity 17(Suppl 2):S111
• Phentermine Therapy in Obesity Treatment: Effect on Blood Pressure 582P.  
  Hendricks EJ, Westman EC, Obesity 16, Supplement 1(October):S216
• A Survey of Prescribing Practices of Medical Bariatricians.  
  Hendricks EJ, Greenway FL, Westman EC, and et al, Obesity 16(October, Supplement 1):S292-293
• Weight Control Pharmacology in Bariatric Surgical Practice.  
  Hendricks EJ, Bariatric Times. Vol 3:1,16-19
• New Drugs for Obesity: Drugs in Phase 1 Clinical Trials.  
  Hendricks EJ, American Journal Bariatric Medicine. 17(2):16
• New Drugs for Obesity: Drugs in Phase 2 Clinical Trials.  
  Hendricks EJ, American Journal Bariatric Medicine. 17(2):17
• New Drugs for Obesity: Drugs in Phase 3 Clinical Trials.  
  Hendricks EJ, American Journal Bariatric Medicine. 16(3):15
• Join now to see all

Books/Book Chapters

• Obesity: Evaluation and Treatment Essentials. 
  Chapter: Pharmcotherapy 
  Page 81 - 99Hendricks EJEditors: Steelman GM, Westman E.Informa Healthcare, New York, NYEdition 1,

Lectures

• Trends in U.S.A. Obesity Treatment. 
  Chinese University of Hong Kong Medical School, Eurodrug Laboratories
• Treatment of Obesity in the post-Sibutramine Era. What Are the Options? 
  Eurodrug Laboratories, Seoul, Korea
• Long-term Phentermine: Weight Loss, Blood Pressure, & Heart Rate Effects. 
  American Society Bariatric Physicians 60th Annual Obesity Seminar, New Orleans
• Is Phentermine Addicting? 
  American Society of Bariatric Physicians, Costa Mesa
• Adverse Reactions to Phentermine, Evidence versus Conjecture. 
  American Society of Bariatric Physicians, Tampa, FL
• ASBP Membership Survey of Prescribing Practices. 
  American Society of Bariatric Physicians, Tampa, FL
• Pharmacotherapy of Obesity. 
  American Board of Bariatric Medicine, Nashville, TN
• Indications for Phentermine Use in Treating Obesity: Re-examination of Current Guidelines. 
  American Society of Bariatric Physicians, Nashville, TN
• Using the Web to Stay Current with Obesity Treatment and Research. 
  56th Annual Obesity & Associated Conditions Symposium, San Diego, CA
• New Obesity Drugs. 
  Eastern Regional Obesity Course, American Society of Bariatric Physicians. Atlanta, GA, 2003
• Insurance Panel Debate: Pros and Cons. 
  55th Annual Obesity & Associated Conditions Symposium. Las Vegas
• New Drugs on the Horizon. 
  51st Annual Obesity & Associated Conditions Symposium, American Society Bariatric Physicians
• The Computerized Laboratory of the Future. 
  Riyadh-Al-Karj Hospital, Riyadh, Saudi Arabia
• Mechanisms of Subspecialty Training: Where -University or Private Hospital. 
  American Society Clinical Pathologists, Monterey, CA
• Use of Amniotic Fluid Analysis in Prenatal Management of Rh Disease. 
  Annual Meeting, Texas Medical Association, Houston, Texas
• Join now to see all